Teladoc Health (NYSE:TDOC) Rating Lowered to “Hold” at Zacks Research

Teladoc Health (NYSE:TDOC) was downgraded by equities research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Monday,Zacks.com reports.

TDOC has been the topic of several other research reports. Citigroup increased their target price on shares of Teladoc Health from $9.50 to $10.50 and gave the stock a “neutral” rating in a research report on Tuesday, October 21st. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, October 8th. Mizuho began coverage on shares of Teladoc Health in a research note on Friday, July 25th. They issued a “neutral” rating and a $10.00 target price for the company. Finally, Evercore ISI decreased their price target on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research report on Thursday, October 30th. Five analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $9.73.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $7.57 on Monday. The firm has a market capitalization of $1.34 billion, a PE ratio of -5.91 and a beta of 1.92. The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21. The business’s 50 day moving average is $8.23 and its 200-day moving average is $7.76.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The firm had revenue of $626.44 million during the quarter, compared to analysts’ expectations of $625.66 million. During the same quarter last year, the company earned ($0.19) earnings per share. The company’s revenue for the quarter was down 2.2% compared to the same quarter last year. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Sell-side analysts predict that Teladoc Health will post -1.16 earnings per share for the current year.

Hedge Funds Weigh In On Teladoc Health

Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in Teladoc Health by 4.2% in the third quarter. Vanguard Group Inc. now owns 21,910,950 shares of the health services provider’s stock valued at $169,372,000 after acquiring an additional 891,732 shares during the last quarter. Geode Capital Management LLC lifted its position in Teladoc Health by 2.1% during the 2nd quarter. Geode Capital Management LLC now owns 4,150,197 shares of the health services provider’s stock valued at $36,153,000 after purchasing an additional 84,356 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in shares of Teladoc Health by 5.2% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,571,673 shares of the health services provider’s stock valued at $20,471,000 after purchasing an additional 127,960 shares during the last quarter. Allianz Asset Management GmbH grew its position in shares of Teladoc Health by 189.2% during the 3rd quarter. Allianz Asset Management GmbH now owns 1,619,391 shares of the health services provider’s stock worth $12,518,000 after buying an additional 1,059,458 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Teladoc Health by 14.8% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,558,369 shares of the health services provider’s stock worth $12,405,000 after buying an additional 200,494 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.